We subsequently analyzed publicly available transcriptomic data from VAT of individuals with obesity (GSE20950) who are insulin sensitive (IS) or insulin resistant (IR) (Figure 1b lower panel), to test if there is a further decline of SLC2A4 expression in the combined obese and insulin resistant state. Here, SLC2A4 is linked to obesity disorder.